Quantbot Technologies’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-4,131
Closed -$29.2K 1639
2024
Q4
$29.2K Buy
+4,131
New +$32.9K ﹤0.01% 1346
2024
Q3
Sell
-7,879
Closed -$50.3K 1607
2024
Q2
$50.3K Buy
7,879
+1,940
+33% +$12.5K ﹤0.01% 1252
2024
Q1
$44.7K Sell
5,939
-11,525
-66% -$105K ﹤0.01% 1342
2023
Q4
$162K Buy
+17,464
New +$143K 0.01% 1070
2022
Q4
Sell
-68,677
Closed -$666K 1841
2022
Q3
$666K Buy
+68,677
New +$909K 0.05% 488
2022
Q2
Sell
-17,926
Closed -$468K 1865
2022
Q1
$468K Buy
17,926
+558
+3% +$15.8K 0.04% 601
2021
Q4
$688K Sell
17,368
-4,215
-20% -$192K 0.06% 448
2021
Q3
$1.08M Buy
21,583
+5,600
+35% +$305K 0.08% 367
2021
Q2
$887K Buy
15,983
+1,940
+14% +$103K 0.07% 385
2021
Q1
$656K Sell
14,043
-3,987
-22% -$193K 0.06% 406
2020
Q4
$784K Buy
+18,030
New +$665K 0.08% 316
2020
Q3
Sell
-5,528
Closed -$161K 1430
2020
Q2
$161K Buy
+5,528
New +$153K 0.02% 478

Other funds holding HCAT

Quantbot Technologies's HCAT Position: Q1 2025 in Review

Quantbot Technologies sold out of Health Catalyst (HCAT) in Q1 2025, closing a stake of 4,131 shares — an estimated $29.2K sold.

Quantbot Technologies first reported a position in HCAT in Q2 2020 and held it in 12 quarters. The position peaked at $1.08M in Q3 2021. 165 funds tracked by Wall St. Rank hold HCAT as of Q1 2025.

  • Quantbot Technologies reported no remaining Health Catalyst position as of Q1 2025 after selling out during the quarter.
  • Quantbot Technologies sold 4,131 Health Catalyst shares in Q1 2025, an estimated $29.2K.
  • Quantbot Technologies first reported a position in Health Catalyst in Q2 2020 and held it in 12 quarters.
  • Quantbot Technologies's Health Catalyst position peaked at $1.08M in Q3 2021.
  • 165 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2025.

Based on Quantbot Technologies's 13F filing for Q1 2025, filed 13 May 2025.